Family pedigree pattern suggestive of germline NF1 carrier state in an asymptomatic indiv...
Детермінований перегляд YAML-сутності з джерельної бази. Клінічний авторитет лишається за вказаними source ID та статусом клінічного sign-off.
| ID | RF-NF1-FAMILY-HISTORY-SUSPICION |
|---|---|
| Тип | Тривожна ознака |
| Статус | переглянуто 2026-05-19 | очікує клінічного підпису |
| Хвороби | DIS-BREAST DIS-GLIOMA-LOW-GRADE DIS-SOFT-TISSUE-SARCOMA |
| Джерела | SRC-NCCN-BREAST-2025 SRC-NCCN-CNS-2025 SRC-NCCN-GENETIC-FAMILIAL-BREAST-OVARIAN-2025 |
Походження тривожної ознаки
| Визначення | Family pedigree pattern suggestive of germline NF1 carrier state in an asymptomatic individual who has NOT yet had germline NF1 sequencing or who does NOT independently meet NIH/Bethesda clinical diagnostic criteria for neurofibromatosis type 1 (full- criteria-met individuals route to the confirmed-carrier RF). NF1 is autosomal-dominant with ~1 in 3000 prevalence — most common single-gene cancer-predisposition syndrome. Triggers include any of (a) first-degree relative with a confirmed NF1 pathogenic / likely-pathogenic variant (carrier-by-descent at-risk individual); (b) first-degree relative with full NIH-criteria-met clinical NF1 diagnosis (cutaneous café-au-lait pattern + neurofibromas) but no confirmatory genetic testing performed on the at-risk individual; (c) family-history pattern of childhood optic pathway glioma in one or more first/second-degree relatives — strongly suggestiv... |
|---|---|
| Клінічний напрям | investigate |
| Категорія | other |
Логіка спрацьовування
{
"any_of": [
{
"finding": "family_nf1_known_pathogenic_variant_fdr",
"value": true
},
{
"finding": "family_first_degree_relative_with_clinical_nf1_diagnosis",
"value": true
},
{
"finding": "family_childhood_optic_pathway_glioma",
"value": true
},
{
"finding": "family_mpnst_in_relatives",
"value": true
}
],
"type": "lab_value"
}
Нотатки
v0.3 Wave M suspicion variant — pre-testing family-history- suspicion counterpart to RF-NF1-CONFIRMED-CARRIER. Fires when family pedigree pattern suggests NF1 carrier state but the at- risk individual has not yet had germline NF1 sequencing AND does not independently meet ≥2 NIH/Bethesda clinical diagnostic criteria. Distinct trigger findings from the confirmed-carrier RF — the confirmed-carrier RF fires on `germline_nf1_pathogenic_ variant_confirmed`, `nih_nf1_clinical_diagnostic_criteria_met`, or `germline_nf1_likely_pathogenic_variant`; this suspicion RF fires on family-history-only findings. NF1 has an important pediatric dimension — at-risk children should have annual clinical evaluation by a pediatrician familiar with NF1 (cutaneous evaluation, neurologic exam, vision testing) before formal genetic testing. Genetic testing may be deferred until age 5-10 in asymptomatic at-risk children where the clinical picture remains equivocal — many NF1 features develop only in childhood and the diagnosis becomes clinically evident with age. Standard pathway includes referral to a specialty NF1 clinic (multidisciplinary — pediatric ophthalmology, genetics, neurology, dermatology) where a...
Де використовується
Indications
IND-NF1-SUSPICION-PREVENTION-EMPIRICAL-SURVEILLANCE- IND-NF1-SUSPICION-PREVENTION-EMPIRICAL-SURVEILLANCEIND-NF1-SUSPICION-PREVENTION-TESTING- IND-NF1-SUSPICION-PREVENTION-TESTING